These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27775842)

  • 1. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Tandon P; Reddy KR; O'Leary JG; Garcia-Tsao G; Abraldes JG; Wong F; Biggins SW; Maliakkal B; Fallon MB; Subramanian RM; Thuluvath P; Kamath PS; Thacker LR; Bajaj JS;
    Hepatology; 2017 Jan; 65(1):217-224. PubMed ID: 27775842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation.
    Choudhary NS; Sonavane A; Saraf N; Saigal S; Rastogi A; Bhangui P; Thiagrajan S; Yadav SK; Saha S; Soin AS
    J Clin Exp Hepatol; 2020; 10(1):37-42. PubMed ID: 32025165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F; Lukowski A
    J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis.
    Peeraphatdit T; Naksuk N; Thongprayoon C; Harmsen WS; Therneau TM; Ricci P; Roberts LR; Chaiteerakij R
    Mayo Clin Proc; 2015 Sep; 90(9):1196-206. PubMed ID: 26249009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MELD-Plus: A generalizable prediction risk score in cirrhosis.
    Kartoun U; Corey KE; Simon TG; Zheng H; Aggarwal R; Ng K; Shaw SY
    PLoS One; 2017; 12(10):e0186301. PubMed ID: 29069090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort.
    Patel R; Poddar P; Choksi D; Pandey V; Ingle M; Khairnar H; Sawant P
    Ann Hepatol; 2019; 18(1):30-39. PubMed ID: 31113606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicarbonate can improve the prognostic value of the MELD score for critically ill patients with cirrhosis.
    Chen CY; Pan CF; Wu CJ; Chen HH; Chen YW
    Ren Fail; 2014 Jul; 36(6):889-94. PubMed ID: 24601755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis.
    Koo JK; Kim JH; Choi YJ; Lee CI; Yang JH; Yoon HY; Choi HJ; Ko SY; Choe WH; Kwon SY; Lee CH
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1209-16. PubMed ID: 23425057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.
    Teh SH; Christein J; Donohue J; Que F; Kendrick M; Farnell M; Cha S; Kamath P; Kim R; Nagorney DM
    J Gastrointest Surg; 2005 Dec; 9(9):1207-15; discussion 1215. PubMed ID: 16332475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.